- Home
- DOW vs IQV Comparison
DOW vs IQV Comparison
Compare DOW & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOW
- IQV
- Stock Information
- Founded
- DOW 2018
- IQV 1982
- Country
- DOW United States
- IQV United States
- Employees
- DOW N/A
- IQV N/A
- Industry
- DOW Major Chemicals
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DOW Industrials
- IQV Health Care
- Exchange
- DOW Nasdaq
- IQV Nasdaq
- Market Cap
- DOW 35.2B
- IQV 38.1B
- IPO Year
- DOW N/A
- IQV 2013
- Fundamental
- Price
- DOW $44.81
- IQV $197.58
- Analyst Decision
- DOW Hold
- IQV Buy
- Analyst Count
- DOW 13
- IQV 16
- Target Price
- DOW $57.00
- IQV $256.60
- AVG Volume (30 Days)
- DOW 7.5M
- IQV 2.2M
- Earning Date
- DOW 10-24-2024
- IQV 10-31-2024
- Dividend Yield
- DOW 6.24%
- IQV N/A
- EPS Growth
- DOW N/A
- IQV 27.98
- EPS
- DOW 1.50
- IQV 7.62
- Revenue
- DOW $43,180,000,000.00
- IQV $15,315,000,000.00
- Revenue This Year
- DOW N/A
- IQV $3.68
- Revenue Next Year
- DOW $4.04
- IQV $4.89
- P/E Ratio
- DOW $29.95
- IQV $25.92
- Revenue Growth
- DOW N/A
- IQV 3.10
- 52 Week Low
- DOW $43.33
- IQV $187.62
- 52 Week High
- DOW $60.69
- IQV $261.73
- Technical
- Relative Strength Index (RSI)
- DOW 30.94
- IQV 35.23
- Support Level
- DOW $43.33
- IQV $187.62
- Resistance Level
- DOW $45.13
- IQV $194.48
- Average True Range (ATR)
- DOW 1.03
- IQV 7.65
- MACD
- DOW -0.14
- IQV -1.39
- Stochastic Oscillator
- DOW 23.16
- IQV 26.00
About DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.